FDA investigating Salmonella outbreak connected to moringa powder

Published on April 3, 2026

The U.S. Food and Drug Administration (FDA) is currently investigating a Salmonella outbreak that appears to be connected to Rosabella-brand moringa capsules. Health officials have reported multiple cases of Salmonella infections in seven states, raising concerns about the safety of the dietary supplement.

As of now, health authorities have confirmed infections in Arizona, California, Colorado, Florida, Illinois, New York, and Texas. The FDA has identified Rosabella-brand moringa capsules as a potential source of the outbreak, prompting consumers to be vigilant. The agency has advised individuals who have purchased these supplements to refrain from using them and to discard any remaining products to prevent further spread of the bacteria.

Symptoms of Salmonella infection can include fever, diarrhea, abdominal cramps, and vomiting, and while most people recover within a week, the infection can be more severe in vulnerable populations, such as the elderly, young children, and individuals with weakened immune systems.

Moringa, often marketed as a nutrient-rich superfood, has gained popularity in recent years due to its purported health benefits. However, the contamination of such products raises serious concerns about quality control and safety standards within the dietary supplement industry.

The FDA is working closely with state and local health officials to trace the source of the contamination and gather more information on the cases linked to the moringa capsules. Consumers are urged to remain informed and report any suspected cases of Salmonella infection, especially if they have recently used the Rosabella-brand moringa capsules.

As the investigation continues, health officials will provide updates on the situation and advise the public on further precautions. In the meantime, consumers are encouraged to prioritize their health and safety the labels of dietary supplements they choose to consume.

Related News